Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations
暂无分享,去创建一个
Reem Alazragi | A. Chettupalli | T. Hussain | J. Barnawi | W. Alelwani | S. Jandrajupalli | A. Unnisa | A. M. Bannunah | B. A. Elamine | P. R. Amarachinta | Omkalthoum A. Mohamed
[1] R. Brandes,et al. Experimental uninephrectomy associates with less parasympathetic modulation of heart rate and facilitates sodium-dependent arterial hypertension , 2022, PloS one.
[2] J. Thireau,et al. Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning , 2021, Pharmaceuticals.
[3] Padmanabha Rao Amarachinta,et al. Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect , 2021, Journal of Nanobiotechnology.
[4] José Juan Escobar-Chávez,et al. Transdermal Delivery Systems for Biomolecules , 2021, Journal of pharmaceutical innovation.
[5] A. Chettupalli,et al. Nanocrystals: Characterization Overview, Applications in Drug Delivery, and Their Toxicity Concerns , 2020, Journal of Pharmaceutical Innovation.
[6] S. Mohammadi-Samani,et al. Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages , 2020, Drug design, development and therapy.
[7] B. Forbes,et al. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters , 2020, Pharmaceutics.
[8] Sarwar Beg,et al. Pharmaceutical Drug Product Development and Process Optimization , 2020 .
[9] K. Dua,et al. Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast , 2020, Dermatologic therapy.
[10] M. Yasir,et al. Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery , 2020, Advanced pharmaceutical bulletin.
[11] V. Sharma,et al. Rational design and in-vivo estimation of Ivabradine Hydrochloride loaded nanoparticles for management of stable angina , 2019 .
[12] S. S. Imam,et al. Formulation of amlodipine nano lipid carrier: Formulation design, physicochemical and transdermal absorption investigation , 2019, Journal of Drug Delivery Science and Technology.
[13] Mayur M. Patel,et al. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis , 2018, Drug development and industrial pharmacy.
[14] R. Ferrari,et al. Treatment of Angina: Where Are We? , 2018, Cardiology.
[15] Karthik Yadav Janga,et al. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation , 2018, Artificial cells, nanomedicine, and biotechnology.
[16] James R. Smith,et al. Liposomal Drug Delivery Systems and Anticancer Drugs , 2018, Molecules.
[17] A. Chauhan. Dendrimers for Drug Delivery , 2018, Molecules.
[18] Neel N. Shah,et al. Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease , 2018, Drug development and industrial pharmacy.
[19] C. Ghelardini,et al. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy , 2018, Drug delivery.
[20] Alexander M. Kiel,et al. Regulation of Coronary Blood Flow. , 2017, Comprehensive Physiology.
[21] A. Ahad,et al. Invasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic study , 2017, Artificial cells, nanomedicine, and biotechnology.
[22] A. Ahad,et al. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment. , 2016, International journal of pharmaceutics.
[23] B. Gidwani,et al. Nanostructured lipid carriers and their current application in targeted drug delivery , 2016, Artificial cells, nanomedicine, and biotechnology.
[24] M. Singh,et al. Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders , 2016, Artificial cells, nanomedicine, and biotechnology.
[25] J. Pizzorno,et al. The Clinician's Handbook of Natural Medicine , 2015 .
[26] S. S. Imam,et al. Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study , 2015, Drug delivery.
[27] T. Garg,et al. Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor , 2015, Journal of drug targeting.
[28] Neeraj Kumar,et al. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment. , 2014, International journal of pharmaceutics.
[29] M. Serin,et al. Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model. , 2014, Pathology, research and practice.
[30] R. Shamma,et al. Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia , 2014, International journal of nanomedicine.
[31] Ding-Yuan Chen,et al. Injectable Cell Constructs Fabricated via Culture on a Thermoresponsive Methylcellulose Hydrogel System for the Treatment of Ischemic Diseases , 2014, Advanced healthcare materials.
[32] Tarun Goyal. Liposomes: Targeted and Controlled Delivery System , 2014 .
[33] V. Patravale,et al. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. , 2013, International journal of pharmaceutics.
[34] E. Oh,et al. Formulation and optimization of spray-dried amlodipine solid dispersion for enhanced oral absorption , 2013, Drug development and industrial pharmacy.
[35] Tarun Goyal. Iontophoresis: Drug Delivery System by Applying an Electrical Potential Across the Skin , 2012 .
[36] R. B. Walker,et al. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers. , 2011, Journal of pharmaceutical sciences.
[37] R. Tan,et al. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables. , 2011, Colloids and surfaces. B, Biointerfaces.
[38] R. Müller,et al. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. , 2011, International journal of pharmaceutics.
[39] S. Chan,et al. Nanosized ethosomes bearing ketoprofen for improved transdermal delivery. , 2011, Results in pharma sciences.
[40] E. Carlson,et al. Human Biology and Health , 2009, The Quarterly Review of Biology.
[41] Xiaoning Zhang,et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. , 2010, International journal of pharmaceutics.
[42] V. Patravale,et al. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. , 2009, International journal of pharmaceutics.
[43] Pál Pacher,et al. Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats , 2008, Nature Protocols.
[44] I. Antal,et al. Application of sucrose fatty acid esters in transdermal therapeutic systems. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[45] M. Matsubara,et al. Effects of benidipine in a rat model for experimental angina. , 2006, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[46] V. Patravale,et al. Formulation and Evaluation of Nanostructured Lipid Carrier (NLC)–based Gel of Valdecoxib , 2006, Drug development and industrial pharmacy.
[47] Jean-Claude Tardif,et al. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. , 2005, European heart journal.
[48] J. Wondergem,et al. Effects of Amifostine on Radiation-induced Cardiac Damage , 2003, Acta oncologica.
[49] G. Lewith. The Clinician's Handbook of Natural Medicine , 2002 .
[50] J. Montani,et al. Direct and indirect methods used to study arterial blood pressure. , 2000, Journal of pharmacological and toxicological methods.
[51] N. Peppas,et al. Mechanisms of solute release from porous hydrophilic polymers , 1983 .
[52] Processed Cheese Science and Technology , 2022 .
[53] V. Kishan,et al. Preparation, Characterization and in vivo Evaluation of Felodipine Solid-Lipid Nanoparticles for Improved Oral Bioavailability , 2015 .
[54] G. Reena,et al. Formulation Development and Characterization of Modified Release Microspheres of Antianginal Drug , 2015 .
[55] P. M. Dandagi,et al. FORMULATION AND EVALUATION OF NANOSTRUCTURED LIPID CARRIER (NLC) OF LORNOXICAM , 2014 .
[56] Xinsheng Peng,et al. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design , 2011 .
[57] Bridget B. Kelly,et al. Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries , 2010 .
[58] D. Favarato,et al. Chronic coronary artery disease , 1999 .
[59] N. Peppas. Analysis of Fickian and non-Fickian drug release from polymers. , 1985, Pharmaceutica acta Helvetiae.
[60] R. Berne,et al. REGULATION OF CORONARY BLOOD FLOW. , 1964, Physiological reviews.